The protease medicines company
Learn more
Catalyst Biosciences Sells Complement Portfolio for $60 Million
Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results
Catalyst Biosciences Reports Fourth Quarter and Year-end 2021 Operating & Financial Results and Provides a Corporate Update
More news
